The US Food and Drug Administration (FDA) has selected the LightLab 3 High Sensitivity (HS) Cannabis Analyzer to play a role in its efforts to regulate the national cannabis industry.
The FDA's decision to deploy LightLab 3 HS Cannabis Analyzer stems from its commitment to address consumer safety concerns associated with food-related products containing CBD and Delta-8 THC. Over the past six years, the FDA has issued numerous consumer safety notices and letters to companies manufacturing or marketing CBD and, more recently, Delta-8 products that fail to comply with various FDA regulations. In addition, the FDA will potentially play a key role in intercepting international and intrastate illicit shipments.
The FDA's move follows the successful deployment of LightLab 3 by the U.S. Customs and Border Protection Agency (CBP) in 2022 after a thorough multi-phase assessment by the CBP's Laboratories and Scientific Services. "We have found that LightLab is very suitable as a quantification tool for cannabis samples," said Josiris Rodriguez, a Chemist with the Customs and Border Protection Agency in San Juan, Puerto Rico.
"The public deserves to have complete confidence in the safety, labeling, and marketing standards of products on retail shelves. State regulatory agencies have successfully relied upon the LightLab 3 Cannabis Analyzer technology for years," states Stephanie McArdle, President of Orange Photonics. "The FDA's adoption of LightLab 3 Cannabis Analyzer is a positive step as it continues to prioritize public health within the current regulatory landscape."
For more information:
176 Newport Road, New London, NH 03257
Tel.: (603) 573-9212